Cuffe Michael S. 4

What Happened
Michael S. Cuffe, Executive Vice President and Chief Clinical Officer of HCA Healthcare (HCA), reported two transactions on Feb 3, 2026: an open-market (or private) sale of 1,500 shares at $498.09 each for total proceeds of $747,135, and a gift of 4,050 shares (reported at $0.00). The Form 4 covering these transactions was filed on Feb 5, 2026.

Key Details

• Transaction date: 2026-02-03; Form 4 filed: 2026-02-05.
• Sale (code S): 1,500 shares @ $498.09 = $747,135 (open market/private sale).
• Gift (code G): 4,050 shares @ $0.00 = $0 (reported as a gift).
• Shares owned after the transactions: not specified in the information provided here.
• No 10b5-1 or tax-withholding footnotes were noted in the supplied summary; filing shows no late-filing indicator.

Context
Sales reduce an insider’s holdings and can be routine (liquidity, diversification, planned sales); gifts are transfers for non-market reasons (estate planning, charitable giving) and do not necessarily signal the insider’s view of the company. There were no option exercises or derivative transactions reported in this filing.